ULURU Inc. exhibits Altrazeal at WOCN

Share this article:
ULURU Inc. announced that six posters detailing clinical experience using Altrazeal Transforming Powder Dressing were presented at the 2010 Wound Ostomy and Continence Nurses Society conference. “We have developed important data on clinical experiences to demonstrate how Altrazeal can provide significant benefits to healthcare professionals and patients in numerous wound types that these nurses routinely treat," said Chris Stergion, the firm's sales and marketing director.
http://www.uluruinc.com/
Share this article:
close

Next Article in Products

More in Products

FDA approves weight management drug

The U.S. Food and Drug Administration has approved Contrave as a treatment for chronic weight management. Contrave is a combination of two FDA-approved drugs, naltrexone and bupropion, in an extended-release formulation.

PDI introduces new swab

PDI introduces new swab

PDI has debuted the Prevantics® Device Swab, a chlorhexidine gluconate/alcohol solution that has received market authorization from the U.S. Food and Drug Administration for disinfecting needleless access sites prior to ...

Oregon Freeze Dry releases Easy Meal

Oregon Freeze Dry releases Easy Meal

A new brand from Oregon Freeze Dry is designed to help long-term care and other healthcare facilities prepare for a disaster.